Latin America Supplement Readiness: Mercosur, Pacific Alliance and National Regimes
Latin America operates as a fragmented regulatory mosaic across the major supplement markets — Brazil (ANVISA), Mexico (COFEPRIS), Argentina (ANMAT and INAL), Chile (ISP and Ministerio de Salud), Colombia (INVIMA), Peru (DIGEMID and DIGESA), Uruguay (MSP) and others — overlaid with the Mercosur customs union (Argentina, Brazil, Paraguay, Uruguay plus associate states) and the Pacific Alliance (Chile, Colombia, Mexico, Peru) economic blocs that drive selective regulatory convergence but do not eliminate per-country registration. Each major market operates its own supplement-or-food-or-medicine classification framework with substantial divergence in scope, evidence requirements, label language (Spanish or Portuguese), and enforcement intensity. This guide covers the regional bloc context, the major-market regimes, common operational themes and the per-country registration discipline.
The regional blocs — Mercosur and Pacific Alliance
Brazil ANVISA — RDC 243/2018 dietary supplements framework
Mexico COFEPRIS — supplemento alimenticio framework and SENICA notification
Argentina, Chile, Colombia, Peru — national regimes
Operational themes — Spanish/Portuguese labelling, importer of record, premium retail and the distributor relationship
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Frequently asked
Does Mercosur membership mean we can register once for Argentina, Brazil, Paraguay and Uruguay together?
Are US DSHEA structure/function claims acceptable in Latin America?
How important is the local distributor relationship for Latin American market entry?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
